Comparative transcriptomic and proteomic profiling of full-length AR and AR-V7 splice variant condensates in prostate cancer
Active Project Grant Awarded Last action
- Award ID
- HT94252510238
- Recipient
-
The University Of British Columbia UEI SJR5MQHSLWT6
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $1,477,615
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date 51% complete
- Place of performance
- 2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Award details come from USAspending.gov.
About this award
The federal Project Grant award of $1,477,615.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will fund comparative transcriptomic and proteomic profiling of full-length androgen receptor (AR) and AR-V7 splice variant condensates in prostate cancer at the University of British Columbia. The research, to be conducted from April 15, 2025 to April 14, 2028, aims to transform healthcare for military service members, veterans, and the broader public by investigating novel diagnostic tools and therapeutic interventions for prostate cancer, a critical health challenge relevant to military personnel. The University of British Columbia, a prominent public research university in Canada, has a strong track record of delivering specialized research services to various U.S. federal agencies through federal grants and contracts.
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| University Of Southern California | $121,688 |
Quick answers
Who received award HT94252510238?
HT94252510238 was awarded to The University Of British Columbia by Defense Health Agency (Department of Defense) on April 15, 2025.
How much is award HT94252510238 worth?
$1,477,615 has been obligated on HT94252510238.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award